Decision Resources, Inc., one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that 56% of primary care physicians and 53% of cardiologists said they would like more than 2 drugs in a single pill combination, according to the new report entitled Combination Cardiovascular Drugs: A Survey of PCPs, Cardiologists, and MCO Pharmacy Directors. When triple-drug single pill combinations were considered, physicians desired the combination of ACEI, beta blocker, and statin.
The report also finds that managed care organization pharmacy directors will relegate Novartis's Norvasc and Diovan combination, Exforge, to tier 3 of their formularies. Sixty-five percent of managed care organizations say they will place Exforge on tier 3, a further 20% say they will exclude the agent from their formularies.
"Tier 3 placement will result in an average patient co-payment of $37.31 in private plans, versus $20.06 for tier 2, and $8.55 for tier 1," said John Earl, Ph.D., director at Decision Resources. "One-third of managed care organizations do expect to give favorable tier status to extended release niacin and simvastatin."
Combination Cardiovascular Drugs: A Survey of PCPs, Cardiologists, and MCO Pharmacy Directors is based on a U.S. survey of 71 primary care physicians, 73 cardiologists, and 17 managed care pharmacy directors. Their responses were compared to assess similarities and differences of opinion regarding clinical, economic, and scientific factors.
About Physician & Payer Forum
Physician & Payer Forum is a primary research service from Decision Resources that offers access to high volume-prescribing physicians, specialists, and managed care organization representatives in the United States; analysis of events and survey participants' responses to them; insight into prescribing patterns; and an examination of the implications of events and issues for the pharmaceutical market.
About Decision Resources
Decision Resources, Inc. (www.decisionresources.com) is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.
All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Elizabeth Marshall Decision Resources, Inc. 781-296-2563 firstname.lastname@example.org
First Call Analyst:
SOURCE: Decision Resources, Inc.
CONTACT: Elizabeth Marshall of Decision Resources, Inc.,
Web site: http://www.decisionresources.com/